PROFESSIONAL_SERVICESONGOING

OHA funds DERP evidence reviews for Medicaid decisions

The Oregon Health Authority spent $100,375 in FFY 2024 to participate in the Drug Effectiveness Review Project, obtaining comparative effectiveness reviews that inform P&T Committee coverage and PDL decisions. DERP participation is funded 50% by state dollars and 50% by federal matching funds.

Document date · September 30, 2024

Track Oregon HA | Oregon Pain Management Commission contracts

Get alerts when new contracts are awarded or existing ones approach renewal at Oregon HA | Oregon Pain Management Commission.

Get started free

Create a free account · no credit card

Trusted by 200+ enterprise customers and 1,000+ teams on the free plan

Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo

Scope & details

The full contract record, as filed.

Contract amount
$100,375 for FFY 2024 (50% state funds, 50% federal matching funds)
Contract type
PROFESSIONAL_SERVICES
Contract term
Federal Fiscal Year 2024
Renewal date
2024-09-30
Renewal
Participation in DERP via a contract with OHSU continued through FFY 2024; specific renewal options or end dates are not provided.
Document type
Report
Source document
Oregon Health Authority Pharmacy & Therapeutics Committee Annual Report 2024

Frequently asked questions

Common questions about this contract, answered from the record.

Who was awarded the professional services contract by Oregon HA | Oregon Pain Management Commission?

Drug Effectiveness Review Project was awarded this professional services contract by Oregon HA | Oregon Pain Management Commission, as recorded on September 30, 2024. The contract value is $100,375 for FFY 2024 (50% state funds, 50% federal matching funds).

How much is the Drug Effectiveness Review Project contract with Oregon HA | Oregon Pain Management Commission worth?

The Drug Effectiveness Review Project contract with Oregon HA | Oregon Pain Management Commission is valued at $100,375 for FFY 2024 (50% state funds, 50% federal matching funds), covering professional services work.

What type of contract is this?

This is a Professional Services contract, documented as a report record.

Where was this contract approved?

This contract appears in Oregon Health Authority Pharmacy & Therapeutics Committee Annual Report 2024 (Report), dated September 30, 2024 from Oregon HA | Oregon Pain Management Commission. Civic IQ extracts contract records directly from agency meeting documents and solicitations.

What other contracts does Drug Effectiveness Review Project hold?

Drug Effectiveness Review Project may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.

View Drug Effectiveness Review Project's profile

What is Oregon HA | Oregon Pain Management Commission currently buying?

Explore Oregon HA | Oregon Pain Management Commission's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.

View Oregon HA | Oregon Pain Management Commission's profile